GLP-1 drugs mimic a hormone in the intestinal tract to balance the body’s blood sugar levels. And while GLP-1 drugs such as ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version between February and March 2025.

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Shortly after the OFA filed its lawsuit, the FDA said it would review its decision to remove Lilly’s tirzepatide products from its shortage list ... Mounjaro and Zepbound have been available ...

Zepbound is a prescription injectable medication that’s used for weight loss. You or a caregiver can administer it as ... cloudy or discolored. If you have questions about how to use Zepbound ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

We recently published a list of 8 Best Low ... a diabetes treatment, and Zepbound, a companion drug for chronic weight management. Both of these products have become significant contributors ...

popular diabetes and weight-loss drugs Mounjaro and Zepbound — is officially over. The news could put pressure on companies that have been able to sell off-brand versions of GLP-1 weight-loss ...

Eli Lilly’s weight loss drug Zepbound is no longer in short supply ... Since the shortage began, specialty and compounding pharmacies have been allowed to sell off-brand versions of the weight ...